In the latest session, Mind Medicine Inc (NASDAQ: MNMD) closed at $9.40 down -1.05% from its previous closing price of $9.50. In other words, the price has decreased by -$0.10 from its previous closing price. On the day, 2159512 shares were traded.
Ratios:
For a deeper understanding of Mind Medicine Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.22 and its Current Ratio is at 3.22. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on December 05, 2023, initiated with a Buy rating and assigned the stock a target price of $9.
On November 16, 2022, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $5.RBC Capital Mkts initiated its Outperform rating on November 16, 2022, with a $5 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 25 ’24 when Barrow Robert sold 16,519 shares for $9.50 per share. The transaction valued at 156,930 led to the insider holds 580,202 shares of the business.
Karlin Dan sold 6,578 shares of MNMD for $62,491 on Mar 25 ’24. The Chief Medical Officer now owns 358,452 shares after completing the transaction at $9.50 per share. On Dec 26 ’23, another insider, Barrow Robert, who serves as the Chief Executive Officer of the company, sold 13,237 shares for $3.63 each. As a result, the insider received 48,050 and left with 596,721 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 664.17M and an Enterprise Value of 578.59M.
Stock Price History:
Over the past 52 weeks, MNMD has reached a high of $11.10, while it has fallen to a 52-week low of $2.41. The 50-Day Moving Average of the stock is 6.08, while the 200-Day Moving Average is calculated to be 4.21.
Shares Statistics:
For the past three months, MNMD has traded an average of 1.92M shares per day and 2.8M over the past ten days. A total of 41.10M shares are outstanding, with a floating share count of 27.05M. Insiders hold about 3.94% of the company’s shares, while institutions hold 61.38% stake in the company. Shares short for MNMD as of Mar 15, 2024 were 5.87M with a Short Ratio of 3.06, compared to 3.43M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.32% and a Short% of Float of 8.37%.
Earnings Estimates
There are 6 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.42 for the current quarter, with a high estimate of -$0.28 and a low estimate of -$0.56, while EPS last year was -$0.65. The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.29 and low estimates of -$0.49.
Analysts are recommending an EPS of between -$1.22 and -$2.07 for the fiscal current year, implying an average EPS of -$1.55. EPS for the following year is -$1.47, with 6 analysts recommending between -$1.16 and -$1.67.
